ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events
Only registered members have full access to PracticeUpdate content.